Yaojia Ma

Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells

Junjie Ao, Tetsuhiro Chiba, Shuhei Shibata et al. · Biochemical and Biophysical Research Communications · 2021 · 31 citations

Medicine, Cancer Biology, Oncology +16

A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis

Takafumi Sakuma, Masato Nakamura, Tetsuhiro Chiba et al. · Laboratory Investigation · 2022 · 24 citations · Full text

Medicine, Biochemistry, Endocrinology +15

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring <i>CTNNB1</i> Mutation in Early Clinical Experience

Keita Ogawa, Hiroaki Kanzaki, Tetsuhiro Chiba et al. · Journal of Cancer · 2022 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma

Junjie Ao, Tetsuhiro Chiba, Hiroaki Kanzaki et al. · Journal of Cancer · 2021 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +17

Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells

T. Iwanaga, Tetsuhiro Chiba, Masato Nakamura et al. · Biochemical and Biophysical Research Communications · 2022 · 14 citations

Life Sciences, Biochemistry, Pathology +15